Molecular Techniques to Detect Disease and Response to Therapy: Minimal Residual Disease
ME Beckner, JA Kant - Molecular Pathology of Hematolymphoid Diseases, 2010 - Springer
Abstract Evaluation for the presence of neoplastic cells or karyotypic abnormalities has
traditionally been performed to monitor therapeutic response of hematolymphoid …
traditionally been performed to monitor therapeutic response of hematolymphoid …
The application of real-time quantitative PCR in the diagnostics of chronic myeloid leukaemia
JJ Van Deventer - 2009 - scholar.ufs.ac.za
CML is a cancer of the white blood cells and it effects on average one individual in every
100,000. Since it was first described in 1845 by John Hughes Bennett and the subsequent …
100,000. Since it was first described in 1845 by John Hughes Bennett and the subsequent …
Evaluation diagnosis of minimal residual disease in chronic myeloid leukemia by Real-Time PCR
AC Grando, SC Wagner - Jornal Brasileiro de Patologia e Medicina …, 2008 - SciELO Brasil
A leucemia mielóide crônica (LMC) representa 15% das leucemias e apresenta três fases:
crônica, acelerada e crise blástica. A partir da análise citogenética, pode ser identificado o …
crônica, acelerada e crise blástica. A partir da análise citogenética, pode ser identificado o …
Diagnostik der minimalen Resterkrankung bei Leukämien durch Echtzeit-Fluoreszenz-PCR
A Bohn, U Lass, KA Kreuzer, H Oettle… - … /Journal of Laboratory …, 2000 - degruyter.com
A. Bohn1, U. Lass1, KA Kreuzer1, H. Oettle1, CA Schmidt1· 2 Zusammenfassung: Die
Diagnose der minimalen Resterkrankung (MRD) bei Leukämien wurde in der …
Diagnose der minimalen Resterkrankung (MRD) bei Leukämien wurde in der …
[PDF][PDF] 저강도전처치동종조혈모세포이식후재발예측을위한정량적키메리즘분석의유용성
김유진， 김동욱， 엄기성， 장필상… - 대한조혈모세포 …, 2004 - oldkmbase.medric.or.kr
Background: Reduced-intensity stem cell transplanta-tion (RIST) has been designed to
minimize transplantrelated toxicity after allogeneic transplantation, but its beneficial effects …
minimize transplantrelated toxicity after allogeneic transplantation, but its beneficial effects …
[PDF][PDF] BIO-TECHNICAL METHODS SECTION (BTS)
X Chen, Q Pan, P Stow, FG Behm, R Goorha, CH Pui… - Leukemia, 2001 - researchgate.net
With a cure rate of 80% in childhood acute lymphoblastic leukemia (ALL), great effort has
been expended to precisely define risk assessment so that intensive treatment is given to …
been expended to precisely define risk assessment so that intensive treatment is given to …
[PDF][PDF] BIO-TECHNICAL METHODS SECTION (BTS)
S Saußele, A Weißer, MC Müller, M Emig, P La Rosée… - Leukemia, 2000 - researchgate.net
BIO-TECHNICAL METHODS SECTION (BTS) Frequent polymorphism in BCR exon b2
identified in BCR-ABL positive and negative individuals Page 1 Leukemia (2000) 14, 2006–2010 …
identified in BCR-ABL positive and negative individuals Page 1 Leukemia (2000) 14, 2006–2010 …
[PDF][PDF] BIO-TECHNICAL METHODS SECTION (BTS)
JQ Guo, H Lin, H Kantarjian, M Talpaz, R Champlin… - Leukemia, 2002 - researchgate.net
Chronic myeloid leukemia (CML) is caused by a Bcr-Abl protein, which results from the
fusion of 5 region of the BCR gene fused to the second exon of the ABL gene. The resulting …
fusion of 5 region of the BCR gene fused to the second exon of the ABL gene. The resulting …
[引用][C] Definition of Remission, Prognosis and Follow Up
MA Sekeres, ME Kalaycio - Clinical Malignant Hematology. 1st ed: The Mc-Graw …, 2007